Page last updated: 2024-09-03

duocarmycin sa and Experimental Mammary Neoplasms

duocarmycin sa has been researched along with Experimental Mammary Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fontaine, SD; Hann, B; Mattis, AN; Renslo, AR; Sambucetti, L; Shi, Y; Spangler, B; Wells, JA1

Other Studies

1 other study(ies) available for duocarmycin sa and Experimental Mammary Neoplasms

ArticleYear
A Novel Tumor-Activated Prodrug Strategy Targeting Ferrous Iron Is Effective in Multiple Preclinical Cancer Models.
    Journal of medicinal chemistry, 2016, 12-22, Volume: 59, Issue:24

    Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Screening Assays, Antitumor; Duocarmycins; Female; Ferrous Compounds; Humans; Indoles; Mammary Neoplasms, Experimental; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Molecular Structure; Prodrugs; Pyrroles; Structure-Activity Relationship; Tumor Cells, Cultured

2016